Gilead Biktarvy expanded indication for HIV-1 treatment in pediatrics gets USFDA okay Ruchika Sharma20 Oct 2021 2:32 PM ISTFoster City: Gilead Sciences, Inc. has announced that the U.S. Food and Drug Administration (USFDA) has approved a new low-dose tablet dosage form of...
Gilead Sciences Lenacapavir MAA gets EMA validation to treat HIV-1 Ruchika Sharma22 Aug 2021 10:00 AM ISTFoster City: Gilead Sciences, Inc. has recently announced that the company's Marketing Authorization Application (MAA) for lenacapavir, an...
BioNTech to buy Kite Gaithersburg manufacturing facility, Neoantigen TCR cell therapy RnD platform Ruchika Sharma20 July 2021 9:00 AM ISTGermany: BioNTech SE and Kite, a Gilead Company have recently announced that the two companies have entered into a purchase agreement...
Covid-19: Govt to import 4.5 lakh vials of Remdesivir Ruchika Sharma1 May 2021 12:25 PM ISTHLL Lifecare Ltd, a government of India owned company, has ordered 4,50,000 vials of Remdesivir from M/s Gilead Sciences Inc USA and Egyptian Pharma...
Gilead Sciences to amplify availability of Remdesivir in India Ruchika Sharma28 April 2021 12:16 PM ISTFoster City: Gilead Sciences has recently announced that in response to the rapid increase in COVID-19 cases in India, the company is providing its...
Gilead Sciences cancer drug Trodelvy gets speedy USFDA approval Ruchika Sharma14 April 2021 4:11 PM ISTFoster City: Drugmaker, Gilead Sciences, has recently announced that the U.S. Food and Drug Administration (USFDA) has granted accelerated...
Cipla doubles covid drug remdesivir production to meet unprecedented demand Ruchika Sharma13 April 2021 4:34 PM ISTThe company is working with authorities to restrict remdesivir supply just to hospitals and places with a high burden of severe COVID-19 cases, Cipla...
Kite seeks USFDA nod for Tecartus to treat Leukemia Ruchika Sharma4 April 2021 10:15 AM ISTSanta Monica: Kite, a Gilead Company, has recently announced that it has submitted a supplemental Biologics License Application (sBLA) to the U.S....
Gilead Sciences application for breast cancer therapy gets EMA validation Ruchika Sharma28 March 2021 11:00 AM ISTFoster City: Gilead Sciences has recently announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application...
Gilead Sciences appoints Flavius Martin as Executive VP, Research Ruchika Sharma27 March 2021 1:46 PM ISTFoster City: Gilead Sciences has recently announced that Flavius Martin, MD will join the company as Executive Vice President, Research, and will...
Zydus reduces COVID-19 drug Remdesivir price to Rs 899 Ruchika Sharma25 March 2021 1:51 PM ISTAhmedabad: In a significant move Zydus has made its brand of Remdesivir, Remdac more affordable at Rs. 899 for a 100 mg lyophilized injection....
Gilead Sciences, Merck collaborate to develop, commercialize Lenacapavir, Islatravir combo for HIV Ruchika Sharma17 March 2021 1:04 PM ISTFoster City & Kenilworth: Gilead Sciences, Inc. and Merck, known as MSD outside the United States and Canada, have recently announced that they...
